ClinicalTrials.Veeva

Menu

Effects of Diet Selection Based on Genetic Screening on Success to a Weight Loss Program (Curves3)

Texas A&M University logo

Texas A&M University

Status

Completed

Conditions

Diet Modification

Treatments

Other: Positive CIQ plus High Protein Diet
Other: Negative CIQ plus High Carbohydrate Diet
Other: Positive CIQ plus High Carbohydrate Diet
Other: Negative CIQ plus High Protein Diet

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03116711
IRB2013-0737F

Details and patient eligibility

About

The purpose of this study is to determine the effects of diet type selection based on response to a Carbohydrate Intolerance Questionnaire (CIQ) and genetic screening on success to a weight loss and exercise program.

Full description

The purpose of this study is to determine if stratification of individuals based on responses to a Carbohydrate Intolerance Questionnaire (CIQ), genetic screening, and/or DNA methylation affects weight loss success and/or health outcomes of women following the Curves moderate carbohydrate, high protein, low fat diet (30% carbohydrate, 45% protein, 25% fat) or the Curves carbohydrate restricted, high protein, moderate fat diet (20% carbohydrate, 45% protein, 35% fat).

Enrollment

51 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The participant is an apparently healthy female
  • The participant is between the ages of 18 and 60

Exclusion criteria

  • The participant is pregnant or nursing, or plans to become pregnant during the next 12 months or has been pregnant in the past 12 months
  • The participant has uncontrolled metabolic disorder including known electrolyte abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease
  • The participant is currently taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive, or androgenic medications
  • The participant has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels (androstenedione, DHEA, etc.) or weight loss (e.g., ephedra, thermogenics, etc.) within the past three months
  • The participant is willing to take participate in a regular moderate exercise program

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

51 participants in 4 patient groups

Positive CIQ plus High Carbohydrate Diet
Active Comparator group
Description:
Positive Carbohydrate Intolerance Questionnaire (CIQ) plus 30% carbohydrate, 45% protein, 25% fat diet
Treatment:
Other: Positive CIQ plus High Carbohydrate Diet
Positive CIQ plus High Protein Diet
Active Comparator group
Description:
Positive Carbohydrate Intolerance Questionnaire (CIQ) plus 20% carbohydrate, 45% protein, 35% fat diet
Treatment:
Other: Positive CIQ plus High Protein Diet
Negative CIQ plus High Carbohydrate Diet
Active Comparator group
Description:
Negative Carbohydrate Intolerance Questionnaire (CIQ) plus 30% carbohydrate, 45% protein, 25% fat diet
Treatment:
Other: Negative CIQ plus High Carbohydrate Diet
Negative CIQ plus High Protein Diet
Active Comparator group
Description:
Negative Carbohydrate Intolerance Questionnaire (CIQ) plus 20% carbohydrate, 45% protein, 35% fat diet
Treatment:
Other: Negative CIQ plus High Protein Diet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems